<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00963742</url>
  </required_header>
  <id_info>
    <org_study_id>IDE G060058</org_study_id>
    <nct_id>NCT00963742</nct_id>
  </id_info>
  <brief_title>Lenstec Softec HD Posterior Chamber Intraocular Lens Clinical Investigational Protocol</brief_title>
  <official_title>Lenstec Softec HD Posterior Chamber Intraocular Lens (PCIOL) Clinical Investigational Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lenstec Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lenstec Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this multi-center clinical investigation are to determine the safety and
      effectiveness of the Lenstec Softec HD Posterior Chamber intraocular lens (IOL) following one
      year of post-operative assessment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Softec HD Posterior Chamber IOL is designed for the treatment of aphakia. The lens is
      indicated for primary implantation when a cataractous lens has been removed by
      phacoemulsification with circular tear capsulotomy and the posterior capsule intact. The
      intended benefit of the Softec HD Posterior Chamber IOL is to provide enhanced vision.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance Best Corrected Visual Acuity</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>FDA IOL Grid Adverse Events</measure>
    <time_frame>through 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">390</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Lenstec Softec HD IOL implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>390 eyes of 390 study subjects all receiving the investigational IOL; IOL implanted after surgical removal of cataract</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lenstec Softec HD IOL implantation</intervention_name>
    <description>surgical removal of cataract and implantation of Softec HD PCIOL</description>
    <arm_group_label>Lenstec Softec HD IOL implantation</arm_group_label>
    <other_name>Softec HD PCIOL</other_name>
    <other_name>Softec HD Posterior Chamber IOL</other_name>
    <other_name>Softec HD Posterior Chamber Intraocular Lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataract requiring cataract extraction

          -  Study IOL to only be implanted in 1 eye

          -  Distance BCVA 20/40 or worse or glare acuity worse than 20/30

          -  Ability to comply with study follow-up requirements

        Exclusion Criteria:

          -  Patients with serious corneal disease, previous surgery or serious systemic disease

          -  Ocular condition that could impact vision after cataract surgery

          -  Pregnant or lactating women

          -  Use of ocular or systemic medications that could impact vision
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald R Sanders, M.D. Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Center for Clinical Research</affiliation>
  </overall_official>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2009</study_first_submitted>
  <study_first_submitted_qc>August 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2009</study_first_posted>
  <last_update_submitted>March 17, 2014</last_update_submitted>
  <last_update_submitted_qc>March 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract surgery</keyword>
  <keyword>IOL</keyword>
  <keyword>Intraocular lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

